Clinical trials: Hair Diseases
Fabry Disease
Androgenetic Alopecia in Fabry Disease
The purpose of this study is to assess whether patients with the classic form of Fabry disease have significantly less androgenic alopecia (male pattern baldness).
- Trial name
- NCT01295008
- Where
- United States
- Volunteers
- 107 people, healthy volunteers welcome
- Sponsor
- Baylor Research Institute
Type 2 Diabetes, Hypertension
Household Participants
Native Hawaiians' traditional lifestyles and diets ensured the mutual health and well-being of the land and its inhabitants, which stand in stark contrast to the disproportionately high prevalence of diet-related, cardiometabolic…
- Conditions
- Type 2 Diabetes, Hypertension, Dyslipidemias, Overweight and Obesity
- Trial name
- NCT06590649
- Testing
- Household-level effects
- Where
- 2 sites in United States
- Volunteers
- 168 people, healthy volunteers welcome
- Sponsor
- University of Hawaii
Alopecia Areata
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Alopecia areata (AA) is a chronic relapsing autoimmune disease characterized by nonscarring hair loss affecting children, adolescents, and adults across all ages, races, and genders.
- Trial name
- PRESTO (NCT06531109)
- Testing
- Ritlecitinib
- Where
- 70 sites in United States, China and 4 more
- Volunteers
- 450 people
- Sponsor
- Pfizer
Alopecia, Androgenetic
STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia
The primary objective of this study is to evaluate the safety and feasibility of the Celution and Puregraft Systems in the processing and preparation of an autologous fat graft enriched with adipose-derived regenerative cells…
- Trial name
- STYLE (NCT02503852)
- Testing
- Puregraft System, Celution System, Kerastem Therapy
- Where
- 4 sites in United States
- Volunteers
- 71 people
- Sponsor
- Kerastem Technologies, LLC
Androgenetic Alopecia
To Evaluate the Pharmacokinetics and Safety of AD-208
To evaluate pharmacokinetics and safety of AD-208.
- Trial name
- NCT04214808
- Testing
- AD-208, Avodart Soft Capsule 0.5mg
- Where
- South Korea
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Addpharma Inc.
Skin-Picking, Trichotillomania (Hair-Pulling Disorder)
Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors
The goal of the proposed study is to compare the efficacy of behavioral treatment (BT) to memantine, a psychopharmacological agent, for BFRBs.
- Trial name
- NCT05796752
- Testing
- Memantine, ComB Behavioral Therapy
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- University of Chicago
Hirsuitism
To Comapre The Effectiveness of Two Lasers in The Treamment of Unwanted Hair
A total of 60 female patients (30 patients in each group) with unwanted facial hair diagnosed by a consultant dermatologist were included in this study.
- Trial name
- NCT05739799
- Testing
- IPL, Diode
- Where
- Pakistan
- Volunteers
- 60 people
- Sponsor
- Combined Military Hospital Abbottabad
Trichotillomania (Hair-Pulling Disorder), Trichotillomania
Leveraging Technological Advancements to Improve the Treatment of Trichotillomania
This project will examine the effect using the Keen 2 on hair pulling styles (automatic and focused), the severity of hair pulling behaviors, and related psychiatric symptoms.
- Conditions
- Trichotillomania (Hair-Pulling Disorder), Trichotillomania, Hair Pulling
- Trial name
- NCT05003401
- Testing
- HabitAware Keen2
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Johns Hopkins University
Alopecia Areata
Healthcare Disparities in Alopecia Areata
Alopecia areata (AA) is a common immune-mediated non-scarring alopecia often associated with substantial morbidity. There are however, limited population-based data on potential disparities in the burden of AA, including across…
- Trial name
- NCT05727306
- Testing
- No intervention
- Where
- United Kingdom
- Volunteers
- 4,052,231 people
- Sponsor
- Momentum Data
Psoriasis
Pythagorean Self-Awareness Intervention on Psoriasis Patients.
This one-arm, pilot, non-randomized, study was conducted at the Specialized Psoriasis Unit of Andreas Syggros Hospital in Athens, Greece.
- Trial name
- PSAIPSORIASI (NCT06691763)
- Testing
- Pythagorean Self-Awareness Intervention for stress management and health promotion
- Where
- Greece
- Volunteers
- 21 people
- Sponsor
- National and Kapodistrian University of Athens
Thinning Hair
A Clinical Study to Evaluate the Safety, Effectiveness and In-Use Tolerability of Hair Growth and Scalp Health Serum in Subjects With Mild to Moderate Hair Thinning.
This is a Prospective, Interventional, Randomized, Double-Blind, Placebo-Controlled, Single-Centre, Clinical Study to Evaluate the Safety, Efficacy and In-Use Tolerability of Fermented Extract Hair Growth and Scalp Health Serum.
- Trial name
- NCT07195487
- Testing
- Fermented Extract Hair Growth and Scalp Health Serum
- Where
- India
- Volunteers
- 34 people
- Sponsor
- NovoBliss Research Pvt Ltd
Alopecia Areata, Alopecia Totalis
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
The main objective of this study is to assess the safety, tolerability and efficacy of ATI-50002 Topical Solution in subjects with unilateral or bilateral loss of eyebrow hair due to alopecia areata (AA), alopecia universalis…
- Conditions
- Alopecia Areata, Alopecia Totalis, Alopecia Universalis
- Trial name
- NCT03551821
- Testing
- ATI-50002
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- Aclaris Therapeutics, Inc.
Alopecia Areata
A Study of JNJ-64304500 in Participants With Alopecia Areata
The purpose of this study is to evaluate the clinical response of 22 weeks of study intervention with JNJ-64304500, compared with placebo, in participants with moderate to severe alopecia areata (AA).
- Trial name
- NCT04740970
- Testing
- JNJ-64304500
- Where
- 22 sites in United States, Australia and 2 more
- Sponsor
- Janssen Research & Development, LLC
Alopecia Areata
Dupilumab in the Treatment of Pediatric Alopecia Areata
This is a prospective, randomized, double-blind, placebo-controlled clinical trial. The study will take place at four sites. This trial will enroll a total of 76 children and adolescents with moderate to severe AA (affecting at…
- Trial name
- PEDAL (NCT05866562)
- Testing
- Dupilumab
- Where
- 5 sites in United States
- Volunteers
- 76 people
- Sponsor
- Icahn School of Medicine at Mount Sinai
Androgenetic Alopecia, Male Pattern Baldness
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)
The purpose of the study is to evaluate the ability of injections of Ji Gami(TM) or Ji Gami(TM) DO in combination with minoxidil to induce hair growth in male and female subjects with hair loss.
- Conditions
- Androgenetic Alopecia, Male Pattern Baldness, Female Pattern Baldness
- Trial name
- NCT01451125
- Testing
- Autologous cultured dermal and epidermal cells
- Where
- 4 sites in United States
- Volunteers
- 43 people, healthy volunteers welcome
- Sponsor
- Aderans Research Institute
Alopecia Areata(AA)
HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
This is a Phase 1, open-label, multi-center, competitive enrollment, and dose-escalation study of HCW9302 in subjects with Alopecia Areata (AA)
- Trial name
- IL-2 (NCT07049328)
- Testing
- HCW9302, an IL-2 fusion protein
- Where
- 3 sites in United States
- Volunteers
- 30 people
- Sponsor
- HCW Biologics
Menkes Disease
Copper Histidinate Treatment for Menkes Disease
This expanded access protocol provides subcutaneous copper histidinate for Menkes disease patients under 6 years of age.
- Trial name
- NCT04074512
- Testing
- copper histidinate
- Where
- 20 sites in United States
- Sponsor
- Sentynl Therapeutics, Inc.
Alopecia Areata
Comparison of Microneedling Along With Topical Vitamin D3 Versus Microneedling in Alopecia Areata
Alopecia areata is a common condition that causes sudden, patchy hair loss on the scalp and other body sites. It is believed to occur when the body's immune system mistakenly attacks the hair follicles, leading to hair loss that…
- Trial name
- NCT07243977
- Testing
- Microneedling + Vitamin D3, Microneedling
- Where
- Pakistan
- Volunteers
- 80 people
- Sponsor
- Services Institute of Medical Sciences, Pakistan
Acne Keloidalis Nuchae
Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy
This study is being done to evaluate the effect of targeted UV-B (a component of sunlight) on the treatment of acne keloidalis nuchae (AKN, or razor bumps on the back of the neck).
- Trial name
- NCT01328080
- Testing
- Targeted UV-B
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- Johns Hopkins University
Alopecia Areata
Topical Cetirizine in Treatment of Localized Alopecia Areata
Evaluate and compare the efficacy and safety of topical cetirizine 1%, versus topical betamethasone valerate 0.1% in the treatment of localized alopecia areata.
- Trial name
- NCT05803070
- Testing
- Topical Cetirizine 1 %, Topical betamethasone valerate 0.1%
- Volunteers
- 59 people
- Sponsor
- Assiut University